← Browse by Condition
Medical Condition

airway disease

Total Trials
3
Recruiting Now
3
Trial Phases
EARLY_Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for airway disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — airway disease Clinical Trials

How many clinical trials are currently recruiting for airway disease?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for airway disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for airway disease?
airway disease research spans Phase 1 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a airway disease clinical trial?
Eligibility criteria for airway disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 3
1
Top Sponsors
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 1 trial
Novlead Inc. 1 trial
Università Vita-Salute San Raffaele 1 trial

Recruiting Clinical Trials

NCT06584786 EARLY_Phase 1
Recruiting
Therapeutic Effects of Jing Si Herbal Tea for COPD
Enrollment
120 pts
Location
Taiwan
Sponsor
Taipei Tzu Chi Hospital, Buddh...
View Trial →
NCT06852911
Recruiting
FeNO Detection in Asthma Diagnosis: A New Technology Approach
Enrollment
170 pts
Location
China
Sponsor
Novlead Inc.
View Trial →
NCT06503016 Phase 3
Recruiting
The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients
Enrollment
400 pts
Location
Italy
Sponsor
Università Vita-Salute San Raf...
View Trial →

Related Conditions

bronchial asthma (1) hypotension (1) consciousness level altered (1) respiratory failure (1) tachypnea (1) bradypnea (1) tachycardia (1) bradycardia (1) cardiac failure (1) cardiac arrest (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology